InvestorsHub Logo
icon url

lightrock

06/23/19 12:45 PM

#22629 RE: sushifishman #22628

Good one

What about the IDMC re: "the only people" who can see or have seen the data...

icon url

greens12

06/23/19 1:08 PM

#22630 RE: sushifishman #22628

Very Nice Article , thankyou for taking the time to write that.

"If Multikine is successful for HNC, then it will be studied for many more types of cancer such as breast and cervical. The market potential is enormous.

We reiterate our $250 per share.

A buyout is always a possibility. Recent buyouts of similar bios have been in the $2B to $12B range, as noted above. Even at $2B, the share price would be about $50 a share...a multi-multi bagger."

CVM Long
icon url

Counterpointer

06/23/19 1:49 PM

#22631 RE: sushifishman #22628

I, as others, appreciate so much what you are doing on this site.

Having written that, excuse my editing penchant:

Would your most recent blog read more effectively and more correctly if the following changes were made?

Paragraph 1 of "Summary"

"We believe that the fact that the trial has yet to reach the last EVENT SUGGESTS that Multikine is working." (No "it" necessary.)

"The longer the endpoint is delayed, the more effective Multikine becomes in terms of PROLONGING LIFE." (Not "prolonging death.")

Alternatively, one could write "...in terms of POSTPONING DEATH."

Just suggestions...Any changes are up to you.
icon url

remittekram

06/26/19 7:58 PM

#22781 RE: sushifishman #22628

New SeekingAlpha Out (by Sushifishman)
Great job as always!

https://seekingalpha.com/instablog/50299941-cvm4life/5319225-ergomeds-stock-tell

I'm curious why this ended up being a blog posting vs a regular article like the last one published May 18th?